Celia Schell

Dr. Celia Schell


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2012 in Foodborne Pathogens and Disease
Verified
Journal Article
Closed access
GDGastón Delpech
Gastón Delpech
GPGisela Pourcel
Gisela Pourcel
CSCelia Schell
Celia Schell
MLMaría De Luca
María De Luca
JBJuan Basualdo
Juan Basualdo
MSMónica Sparo
Mónica Sparo
Enterococci are part of the indigenous microbiota of human gastrointestinal tract and food of animal origin. Enterococci inhabiting non-human reservoirs play a critical role in the acquisition and dissemination of antimicrobial resistance determinants. The aim of this work was to investigate the antimicrobial resistance in Enterococcus faecalis and Enterococcus faecium strains recovered from artisanal food of animal origin. Samples of goat cheese ( n =42), cow cheese ( n =40), artisanal salami ( n =30), and minced meat for the manufacture of hamburgers ( n =60) were analyzed. Phenotypic and genotypic tests for species-level identification of the recovered isolates were carried out. Minimum inhibitory concentration (MIC) study for i n vitro quantitative antimicrobial resistance assessment was performed, and 71 E. faecalis and 22 E. faecium were isolated. The recovered enterococci showed different multi-drug resistance patterns that included tretracycline, erythromycin, ciprofloxacin, linezolid, penicillin, ampicillin, vancomycin, teicoplanin, gentamicin (high-level resistance), and streptomycin (high-level resistance). VanA-type E. faecium were detected. β-lactamase activity was not observed. Artisanal foods of animal origin act as a non-human reservoir of E. faecalis and E. faecuim strains, expressing multi-resistance to antimicrobials. In conclusion, the implementation of a continuous antimicrobial resistance surveillance in enterococci isolated from artisanal food of animal origin is important.

31 July 2008 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
CBCarlos Bantar
Carlos Bantar
CSCelia Schell
Celia Schell
GPGraciela Posse
Graciela Posse
ALAdriana Limansky
Adriana Limansky
VBViviana Ballerini
Viviana Ballerini
LMLiliana Mobilia
Liliana Mobilia

20 February 2020 in Pathogens
Verified
Journal Article
Open access
PDF file
CSCelia Schell
Celia Schell
Ana P. TedimAna P. Tedim
Ana P. Tedim
MRMercedes Rodríguez-Baños
Mercedes Rodríguez-Baños
MSMónica Delfina Sparo
Mónica Delfina Sparo
SLSabina Lissarrague
Sabina Lissarrague
TCTeresa M. Coque
Teresa M. Coque
The study’s aim was to analyze the population structure of enterococci causing human invasive infections in a medium-sized Argentinian Hospital coincidental with a 5 year-period of increased recovery of antibiotic resistant enterococci (2010–2014). Species identification (biochemical testing/MALDI-TOF-MS), antimicrobial susceptibility (disk-diffusion) and clonal relatedness (PFGE/MLST/BAPS) were determined according to standard guidelines. β-lactamase production was determined by a nitrocefin test and confirmed by PCR/sequencing. The isolates were identified as Enterococcus faecalis and Enterococcus faecium at a 2:1 ratio. Most of the E. faecalis isolates, grouped in 25 PFGE-types (ST9/ST179/ST236/ST281/ST388/ST604/ST720), were resistant to high-levels (HLR) of gentamicin/streptomycin. A ST9 clone (bla+/HLR-gentamicin) was detected in patients of different wards during 2014. E. faecium isolates were grouped in 10 PFGE-types (ST25/ST18/ST19/ST52/ST792), with a low rate of ampicillin resistance. Five vancomycin-resistant E. faecium, three vanA (ST792/ST25) and two vanB (ST25) were detected. The ST25 clone carried either vanA or vanB. The recovery of a bla+-ST9-E. faecalis clone similar to that described in the late 1980s in Argentina suggests the possibility of a local hidden reservoir. These results reflect the relevance of local epidemiology in understanding the population structure of enterococci as well as the emergence and spread of antimicrobial resistance in predominant enterococcal clonal lineages.

29 March 2022 in Actualizaciones en Sida e Infectología
Verified
Journal Article
Open access
PDF file
JSJuan Pablo Stagnaro
Juan Pablo Stagnaro
SLSabina Lisarrague
Sabina Lisarrague
JBJudith Celina Bernstein
Judith Celina Bernstein
CSCelia Schell
Celia Schell
EFEduardo Fortunato
Eduardo Fortunato
MSMónica Delfina Sparo
Mónica Delfina Sparo
Las infecciones de piel y partes blandas (IPPB) en niños son una de las principales causas de prescripción de antimicrobianos. El objetivo del estudio fue describir las características clínicas y microbiológicas de las IPPB ambulatorias de niños asistidos en dos hospitales zonales. Se realizó un estudio prospectivo entre 1/11/2017 y 1/11/2018. Se incluyeron pacientes entre 1 mes y 15 años, internados en dos hospitales. Se evaluó: edad, sexo, localidad, factores predisponentes, tipo de IPPB, muestras biológicas realizadas, aislamiento microbiológico, tratamiento empírico indicado y evolución del cuadro. Se realizó antibiograma y determinación genética. Se calculó chi2, IC95, OR; α=5%. N= 94. 58,7% masculinos. 12 pacientes 1 año (promedio de edad 4 años, 1-15). El 36% de Tandil y 63,8% de Florencio Varela. El 59,6% corresponden a IPPB purulentas. El rédito diagnóstico fue de 59,6%. Los aislamientos principales: SAMR (40,4%), SAMS (7,4%), S. agalactiae (2,1%) y S. pyogenes (2,1%). El 100% de SAMR son portadores de gen mecA y SCCmec tipo IV, sin multirresistencia. No hubo diferencia estadística entre los factores de riesgo evaluados. El 52,1% de los niños recibió tratamiento antibiótico combinado, siendo la más indicada TMS-SMX + CLI en 36 eventos. (38,3%). La evolución fue favorable ambos grupos: no hubo diferencia significativa entre el subgrupo que se aisló SAMR y el subgrupo que no se aisló SAMR; 91,9% (34/37) y 92,6% (50/54) correspondientemente (chi2: 0,01; p= 0,97 IC95: 0,26-3,88). El principal agente etiológico fue SAMRco, debiendo adecuar los tratamientos a este microorganismo.

21 February 2024 in Asian Journal of Research in Infectious Diseases
Verified
Journal Article
Open access
PDF file
CSCelia Schell
Celia Schell
VBVíctor Sebastián Blancato
Víctor Sebastián Blancato
RCRuth Jésica Carbone
Ruth Jésica Carbone
MMMaría Josefina Mauro
María Josefina Mauro
VTVanina Torres
Vanina Torres
CMchristian magni
christian magni
Aims: The surveillance and investigation of antimicrobial resistance and virulence factor genes in nosocomial pathogens such as Enterococcus spp. have not been adequately prioritized within health institutions, especially in the context of COVID-19. The objective of this work was to conduct an epidemiological and molecular study in multidrug-resistant Enterococcus spp. strains isolated from hospitalized patients using a "One Health" approach in the middle of the COVID-19 pandemic. Study Design: An observational, prospective, cross-sectional study was designed. All strains were isolated from hospitalized patients in a public hospital in La Plata, Buenos Aires, Argentina from September 2019 to August 2021; coincidental with the COVID-19 pandemic. Methodology: In this study, we used N=17 Enterococcus spp. detected by biochemical testing and BD Phoenix™ M50: E. faecalis (n=6) and E. faecium (n=11). Antimicrobial susceptibility was determined according to standard guidelines (disk diffusion and MIC). AR and VF genes were detected by PCR assays. Results: 10/11 (90.9%) vancomycin-resistant E. faecium strains were confirmed by molecular test. The highest detection of vanA-VREFM resulted after the pandemic cohort (2021). Resistance to glycopeptides was associated with resistance to ß-lactams and high-level resistance to aminoglycosides. The gen aac(6′)-Ie-aph(2″)-Ia was detected in E. faecium (n=7) and E. faecalis (n=1). The esp gene (52.9%) was the most frequent virulence factor, followed by gelE 7 (41.2%) and cylA 1 (5.9%) among E. faecalis and E. faecium isolates. Conclusions: Nosocomial pathogens and commensal bacteria such as Enterococcus have an essential role in spreading AR and VF using genome plasticity to transfer genes located in MGE. The epidemiological and molecular investigation of multidrug-resistant strains allows adjusting biosafety protocols to prevent their spread.